The Aspen Group’s Manufacturing Capabilities
Pharmaceutical manufacture remains one of the Aspen Group’s cornerstones to success. Within just over a decade, the Group’s global manufacturing footprint has expanded significantly. Aspen’s portfolio consists of branded, generic, OTC, consumer health and infant nutritional products which range across a number of key therapeutic categories and which are registered in accordance with the regulatory requirements specific to each market.
Aspen continues to increase the number of lives benefiting from its product, reaching more than 150 countries across the world. The extensive basket of Aspen products provides treatment for a broad spectrum of acute and chronic conditions experienced throughout all stages of life.
Aspen has 26 pharmaceutical manufacturing facilities on 18 pharmaceutical manufacturing sites on 6 continents. Click here to view Aspen’s global manufacturing capabilities as published in the 2014 Integrated Report.